SCHEMBL20661055

SCHEMBL20661055

Cc1ccc(-c2nc(C3CCN(C(=O)C4CC(=O)N(c5cccc(C)c5C)C4)CC3)no2)cc1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.48
▸ PKM P14618 1/20 0.48
▸ HTT P42858 2/20 0.48
▸ KMT2A Q03164 2/20 0.45
▸ GFER P55789 1/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ TP53 P04637 2/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ HSD11B1 P28845 1/20 0.43
▸ TSHR P16473 2/20 0.42
▸ LMNA P02545 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ USP7 Q93009 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20676466 0.85 MEN1 (0.49) MAPTHTTKMT2ASMN1; SMN2ALDH1A1
SCHEMBL20117112 0.85 MEN1 (0.49) MAPTHTTKMT2ASMN1; SMN2ALDH1A1
SCHEMBL20116235 0.85 MEN1 (0.49) MAPTHTTKMT2ASMN1; SMN2ALDH1A1
SCHEMBL20117115 0.79 GRM5 (0.49) MAPTKMT2ASMN1; SMN2TP53MEN1
SCHEMBL20117114 0.79 GRM5 (0.49) MAPTKMT2ASMN1; SMN2TP53MEN1
SCHEMBL20116255 0.79 GRM5 (0.49) MAPTKMT2ASMN1; SMN2TP53MEN1
SCHEMBL20660846 0.78 MAPT (0.61) MAPTPKMHTTKMT2ASMN1; SMN2
SCHEMBL20117003 0.71 MAPT (0.56) MAPTHTTSMN1; SMN2TP53ALDH1A1
SCHEMBL30720981 0.71 MAPT (0.56) MAPTHTTSMN1; SMN2TP53ALDH1A1
SCHEMBL20116140 0.71 MAPT (0.56) MAPTHTTSMN1; SMN2TP53ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3700934-A1 COMPOUNDS AND USES THEREOF Yumanity Therapeutics, Inc. (US) 2020-09-02 — — EP disclosed
WO-2019018795-A1 COMPOUNDS AND USES THEREOF YUMANITY THERAPEUTICS (US) 2019-01-24 — — WO disclosed
Send feedback